Citigroup’s Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A BSX.PRA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-47,500	Closed	-$5.75M	–	5051
2023 Q1	$5.75M	Buy	47,500 +29,447	+163%	+$3.56M	﹤0.01%	1059
2022 Q4	$2.07M	Buy	+18,053	New	+$2.07M	﹤0.01%	1499
2020 Q4	–	Sell	-200	Closed	-$22K	–	5322
2020 Q3	$22K	Buy	+200	New	+$22K	﹤0.01%	3921